Patents Assigned to Viva Pharmaceutical Inc.
-
Patent number: 9597308Abstract: A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to zinc to form a chelate ring. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with zinc. A compound having a chelate formulation with zinc being chelated by an N-acetyl-L-cysteine ligand.Type: GrantFiled: May 15, 2015Date of Patent: March 21, 2017Assignee: Viva Pharmaceutical, Inc.Inventors: Xueju Xie, Rhett Sean Daniels
-
Patent number: 9186385Abstract: A composition for affecting one or more of influenza, inflammation, and immune system function, said composition comprising an extract prepared from Radix isatidis and an extract prepared from Flos Lonicerae. In alternative embodiments, the composition further comprises one or more of an extract prepared from Poria cocos(Schw.) Wolf and an extract prepared from Herba houttuyniae. Method for treating one or more of influenza, inflammation by administering a patient a therapeutically effective amount of the above composition.Type: GrantFiled: March 2, 2010Date of Patent: November 17, 2015Assignee: Viva Pharmaceutical Inc.Inventors: Xueju Xie, Jason Jiang-Chung Ko
-
Patent number: 9062086Abstract: A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring. A method for preparing a chelate comprised of N-acetyl-L-cysteine ligand and a metal having the steps of: dissolving an amount of N-acetyl-L-cysteine in an aqueous solution, adding a metal to the aqueous solution, stifling and heating the aqueous solution, and removing the solvent under reduced pressure. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with a metal. A compound having a chelate formulation with a metal being chelated by an N-acetyl-L-cysteine ligand.Type: GrantFiled: December 27, 2013Date of Patent: June 23, 2015Assignee: Viva Pharmaceutical, Inc.Inventors: Xueju Xie, Rhett Sean Daniels, Patricia Gahan
-
Publication number: 20120107395Abstract: Soft gel capsules are formed from an outer gelatin-containing shell and a filling. The filling includes a probiotic and a dessicant.Type: ApplicationFiled: December 7, 2010Publication date: May 3, 2012Applicant: VIVA PHARMACEUTICAL INC.Inventors: Xueju Xie, Jason Jiang-Chung Ko
-
Patent number: 7968128Abstract: A composition for affecting physiological sleep disorders comprising a therapeutically effective amount of Baiziren extract or any of its derivatives, and a pharmaceutically acceptable carrier. The composition may additionally comprise a therapeutically effective amount of at least one of a Suanzaoren extract and a Yuanzhi extract, or mixtures thereof.Type: GrantFiled: November 3, 2008Date of Patent: June 28, 2011Assignee: VIVA Pharmaceutical Inc.Inventors: Xueji Xie, Yu-Lung Ko, Chien-Kuang Ko, Jason Jiang-Chung Ko, Richard William Gafney
-
Publication number: 20100226936Abstract: A composition for affecting one or more of influenza, inflammation, and immune system function, said composition comprising an extract prepared from Radix isatidis and an extract prepared from Flos Lonicerae. In alternative embodiments, the composition further comprises one or more of an extract prepared from Poria cocos(Schw.) Wolf and an extract prepared from Herba houttuyniae. Method for treating one or more of influenza, inflammation by administering a patient a therapeutically effective amount of the above composition.Type: ApplicationFiled: March 2, 2010Publication date: September 9, 2010Applicant: VIVA PHARMACEUTICAL INC.Inventors: Xueju XIE, Jason Jiang-Chung KO
-
Publication number: 20100112107Abstract: A composition for affecting physiological sleep disorders comprising a therapeutically effective amount of Baiziren extract or any of its derivatives, and a pharmaceutically acceptable carrier. The composition may additionally comprise a therapeutically effective amount of at least one of a Suanzaoren extract and a Yuanzhi extract, or mixtures thereof.Type: ApplicationFiled: November 3, 2008Publication date: May 6, 2010Applicant: VIVA PHARMACEUTICALS INC.Inventors: Xueji XIE, Yu-Lung KO, Chien-Kuang KO, Jason Jiang-Chung KO, Richard William Gafney
-
Publication number: 20100092548Abstract: A chewable softgel capsule configured for encasing orally ingestible articles. The chewable soft capsule is provided with an outer shell composition which comprises at least one gelatin in a range of 20% to 60% of the total weight of the shell composition, at least one plasticizer in an amount selected to render flexible the outer shell composition, an anti-tacking agent in an amount selected to render the outer shell composition non-sticky, and water. In one embodiment the chewable soft capsule further comprises at least one starch in a range of 0.1% to 35% of the total weight of the shell composition. The chewable softgel capsule is suitable for encasing therein medicines, pharmaceutical compositions, nutraceuticals, vitamins, nutritional supplements, and the like.Type: ApplicationFiled: August 6, 2009Publication date: April 15, 2010Applicant: VIVA PHARMACEUTICALS INC.Inventors: Xueju Xie, Yu-Lung Ko, Chien-Kuang Ko, Jason Jiang-Chung Ko
-
Publication number: 20100055174Abstract: A chewable softgel capsule configured for encasing orally ingestible articles. The chewable soft capsule is provided with an outer shell composition which comprises at least one gelatin in a range of 20% to 60% of the total weight of the shell composition, at least one plasticizer in an amount selected to render flexible the outer shell composition, an anti-tacking agent in an amount selected to render the outer shell composition non-sticky, and water. In one embodiment the chewable soft capsule further comprises at least one starch in a range of 0.1% to 35% of the total weight of the shell composition. The chewable softgel capsule is suitable for encasing therein medicines, pharmaceutical compositions, nutraceuticals, vitamins, nutritional supplements, and the like.Type: ApplicationFiled: August 18, 2009Publication date: March 4, 2010Applicant: Viva Pharmaceutical Inc.Inventors: Xueju XIE, Yu-Lung KO, Chien-Kuang KO, Jason Jiang-Chung KO
-
Patent number: 7662406Abstract: A chewable softgel capsule configured for encasing orally ingestible articles. The chewable soft capsule is provided with an outer shell composition which comprises at least one gelatin in a range of 20% to 60% of the total weight of the shell composition, at least one plasticizer in an amount selected to render flexible the outer shell composition, an anti-tacking agent in an amount selected to render the outer shell composition non-sticky, and water. In one embodiment the chewable soft capsule further comprises at least one starch in a range of 0.1% to 35% of the total weight of the shell composition. The chewable softgel capsule is suitable for encasing therein medicines, pharmaceutical compositions, nutraceuticals, vitamins, nutritional supplements, and the like.Type: GrantFiled: August 18, 2009Date of Patent: February 16, 2010Assignee: Viva Pharmaceutical Inc.Inventors: Xueju Xie, Yu-Lung Ko, Chien-Kuang Ko, Jason Jiang-Chung Ko
-
Publication number: 20090136650Abstract: A dry suspendible enteric coating composition for suspension in water and then encasing orally ingestible articles. The dry suspendible enteric coating composition comprises a pH-dependent polymer selected from a group containing alginates and alginic acids, a pH-independent water insoluble polymer selected from the group comprising ethylcellulose and ethylcellulose-containing compositions, and a plasticizer selected from the group containing triethyl citrate, glycerin, propylene glycol, triacetin, acetylated monoglycerides, dibutyl sebacate, polyethylene glycols, sorbitals, middle chain triglycerides and combinations thereof.Type: ApplicationFiled: November 24, 2008Publication date: May 28, 2009Applicant: VIVA PHARMACEUTICALS INC.Inventors: Xueju XIE, Yu-Lung (Edward) KO, Chien-Kuang (David) KO, Jason Jiang-Chung KO
-
Publication number: 20090074855Abstract: A suspendible enteric coating composition for encasing orally ingestible articles wherein the enteric coating composition comprises a pH-dependent polymer selected from a group containing alginates and alginic acids, a pH-independent water insoluble polymer selected from the group comprising ethylcellulose and ethylcellulose-containing compositions, and a plasticizer selected from the group containing triethyl citrate, glycerin, propylene glycol, triacetin, acetylated monoglycerides, dibutyl sebacate, polyethylene glycols, sorbitals, middle chain triglycerides and combinations thereof.Type: ApplicationFiled: February 26, 2008Publication date: March 19, 2009Applicant: VIVA PHARMACEUTICALS INC.Inventors: Xueju Xie, Yu-Lung Ko, Chien-Kuang Ko, Jason Jiang-Chung Ko
-
Publication number: 20090074944Abstract: A suspendible enteric coating composition for encasing orally ingestible articles wherein the enteric coating composition comprises a pH-dependent polymer selected from a group containing alginates and alginic acids, a pH-independent water insoluble polymer selected from the group comprising ethylcellulose and ethylcellulose-containing compositions, and a plasticizer selected from the group containing triethyl citrate, glycerin, propylene glycol, triacetin, acetylated monoglycerides, dibutyl sebacate, polyethylene glycols, sorbitals, middle chain triglycerides and combinations thereof.Type: ApplicationFiled: January 24, 2008Publication date: March 19, 2009Applicant: VIVA PHARMACEUTICALS INC.Inventors: Xueju XIE, Edward Ko, David Ko, Jason Jiang-Chung Ho